LEO Pharma A/S today announced that new data being presented at the 23 rd World Congress of Dermatology shows aerosol foam Enstilar ® (calcipotriol/betamethasone ...

Deucravacitinib was effective and worked faster than placebo through 52 weeks in patients with moderate-to-severe plaque psoriasis. The phase 3 trial, which appears in the Journal of Dermatological ...

Psoriasis, a chronic autoimmune condition, causes inflammation in the skin, most often leading to thick, scaly areas called plaques. An overactive immune system speeds up skin cell development, ...